Literature DB >> 24831265

Significance of the cribriform pattern in prostatic adenocarcinomas.

Billur Cosan Sarbay1, Gozde Kir2, Cumhur Selcuk Topal2, Eyup Gumus3.   

Abstract

INTRODUCTION: There is now increased understanding that invasive cribriform carcinoma is a relatively aggressive disease. In some recent publications, the recommendation is that all cribriform patterns be classified as Gleason pattern (GP) 4 rather than GP 3.
MATERIALS AND METHODS: We assessed the cribriform foci (CF) associated with the more definitive patterns 3, 4, and 5 elsewhere on the 185 radical prostatectomy specimens and evaluated the association of the cribriform pattern with extraprostatic extension, surgical margin.
RESULTS: CF were more frequently observed in cases with definitive patterns 4 and 5 than in cases with pattern 3 (all cases with pattern 5 exhibited CF). Cases with Gleason score 3+3 and CF were more frequently associated with extraprostatic extension, and a positive surgical margin.
CONCLUSIONS: Our results demonstrate that diagnosing all cribriform patterns as at least GP 4 would significantly affect further therapeutic options and prognosis. However, as many of these modifications are empirical and supported by only a few studies, long-term follow-up studies with clinical endpoints are necessary to validate these recommendations.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cribriform pattern; Extraprostatic extension; Gleason score; Prostate cancer

Mesh:

Year:  2014        PMID: 24831265     DOI: 10.1016/j.prp.2014.03.003

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  13 in total

1.  [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Authors:  G Kristiansen; L Egevad; M Amin; B Delahunt; J R Srigley; P A Humphrey; J I Epstein
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

Review 2.  Grading of Prostate Cancer: Past, Present, and Future.

Authors:  Andres Matoso; Jonathan I Epstein
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

Review 3.  On cribriform prostate cancer.

Authors:  Charlotte F Kweldam; Theodorus van der Kwast; Geert J van Leenders
Journal:  Transl Androl Urol       Date:  2018-02

Review 4.  An Updated Review of Cribriform Carcinomas with Emphasis on Histopathological Diagnosis and Prognostic Significance.

Authors:  Giovanni Branca; Antonio Ieni; Valeria Barresi; Giovanni Tuccari; Rosario Alberto Caruso
Journal:  Oncol Rev       Date:  2017-03-10

5.  Human Epidermal Growth Factor Receptor 2 Status in Gastric Carcinomas with Distinctive Prevalent Cribriform Component.

Authors:  Antonio Ieni; Giuseppe Angelico; Valeria Barresi; Giuseppe Giuffrè; Francesco Arena; Rosario Alberto Caruso; Giovanni Tuccari
Journal:  Dis Markers       Date:  2018-02-18       Impact factor: 3.434

6.  Persistent Homology for the Quantitative Evaluation of Architectural Features in Prostate Cancer Histology.

Authors:  Peter Lawson; Andrew B Sholl; J Quincy Brown; Brittany Terese Fasy; Carola Wenk
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

7.  The current status of renal cell carcinoma and prostate carcinoma grading.

Authors:  Brett Delahunt; Lars Egevad; John Yaxley; Hemamali Samaratunga
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

Review 8.  Grading of prostatic adenocarcinoma: current state and prognostic implications.

Authors:  Jennifer Gordetsky; Jonathan Epstein
Journal:  Diagn Pathol       Date:  2016-03-09       Impact factor: 2.644

9.  Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.

Authors:  Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Jozien Helleman; Monique J Roobol; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2018-10-22       Impact factor: 7.842

10.  Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.

Authors:  Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Monique J Roobol; Jozien Helleman; Geert J L H van Leenders
Journal:  Histopathology       Date:  2020-04       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.